US3862175A
(en)
*
|
1965-03-25 |
1975-01-21 |
Fison House |
Bis-chromone compounds
|
GB1144905A
(en)
*
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
GB1147976A
(en)
*
|
1965-12-21 |
1969-04-10 |
Fisons Pharmaceuticals Ltd |
Chromone derivatives
|
GB1190193A
(en)
*
|
1966-07-05 |
1970-04-29 |
Fisons Pharmaceuticals Ltd |
Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
|
US3957965A
(en)
*
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
US3860618A
(en)
*
|
1967-08-08 |
1975-01-14 |
Philip Saxton Hartley |
Chromone
|
GB1292601A
(en)
*
|
1968-10-30 |
1972-10-11 |
Fisons Pharmaceuticals Ltd |
Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them
|
GB1340512A
(en)
*
|
1970-01-21 |
1973-12-12 |
Fisons Ltd |
Production of esters of chromone-2-carboxylic acids
|
GB1326745A
(en)
*
|
1970-04-25 |
1973-08-15 |
Fisons Ltd |
Chromone-2-carboxylic acid derivatives
|
US3979407A
(en)
*
|
1970-07-31 |
1976-09-07 |
Allen & Hanburys Limited |
Chromone derivatives
|
US4029802A
(en)
*
|
1970-08-27 |
1977-06-14 |
Fisons Limited |
The treatment of asthma, hay fever or urticaria
|
US3968235A
(en)
|
1970-12-14 |
1976-07-06 |
Sandoz Ltd. |
Composition and method for combating insects with alkylenedioxyphenyl derivatives
|
US3933804A
(en)
|
1970-12-14 |
1976-01-20 |
Sandoz Ltd., (Sandoz Ag) |
Insecticidal 1,3-benzodioxol derivatives
|
US4105781A
(en)
*
|
1970-12-30 |
1978-08-08 |
Fujisawa Pharmaceutical Co., Ltd. |
Chromone compounds and preparation thereof
|
US3965122A
(en)
*
|
1970-12-30 |
1976-06-22 |
Fujisawa Pharmaceutical Co., Ltd. |
Chromone compounds and preparation thereof
|
GB1399834A
(en)
*
|
1971-05-12 |
1975-07-02 |
Fisons Ltd |
Pharmaceutical compositions
|
US3975536A
(en)
|
1971-05-12 |
1976-08-17 |
Fisons Limited |
Composition
|
US4053628A
(en)
*
|
1971-05-12 |
1977-10-11 |
Fisons Limited |
Composition
|
US4006245A
(en)
*
|
1971-07-29 |
1977-02-01 |
Fisons Limited |
Chemical compounds
|
GB1384530A
(en)
*
|
1971-07-29 |
1975-02-19 |
Fisons Ltd |
Chromone derivatives
|
GB1410588A
(en)
*
|
1971-08-10 |
1975-10-22 |
Fisons Ltd |
Composition
|
SU469247A3
(ru)
*
|
1972-01-14 |
1975-04-30 |
Майлз Лабораториз Инк (Фирма) |
Способ получени производных хромона
|
GB1428186A
(en)
*
|
1972-06-21 |
1976-03-17 |
Fujisawa Pharmaceutical Co |
Chromone derivatives
|
FR2196795A1
(en)
*
|
1972-08-25 |
1974-03-22 |
Aries Robert |
Amine salts of bis(carboxychromones) - useful for treatment of dyspnoea and bronchoconstriction
|
GB1399647A
(en)
*
|
1972-12-15 |
1975-07-02 |
Fisons Ltd |
Phenoxyalkoxy-chromone derivatives processes for their preparation and compositions containing them
|
FR2210398A1
(en)
*
|
1972-12-20 |
1974-07-12 |
Aries Robert |
Bis-(carboxy-chromone) amino ethoxy-ethyl carboxylate salts - useful as a sedative and prophylactic
|
US3948954A
(en)
*
|
1973-01-19 |
1976-04-06 |
Fisons Limited |
Bis-chromone-tetrazole/hydroxamic/carboxylic acids
|
FR2217004A1
(en)
*
|
1973-02-15 |
1974-09-06 |
Aries Robert |
Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
|
FR2230358A2
(en)
*
|
1973-05-25 |
1974-12-20 |
Fisons Ltd |
Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
|
US4046910A
(en)
*
|
1974-01-28 |
1977-09-06 |
The Upjohn Company |
Dosage schedule
|
IL48360A
(en)
*
|
1974-11-09 |
1978-12-17 |
Fisons Ltd |
Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
|
DE2634908A1
(de)
*
|
1974-11-09 |
1977-04-14 |
Fisons Ltd |
Mittel zur behandlung chronischer haut- oder augenerkrankungen
|
US4161516A
(en)
*
|
1975-07-25 |
1979-07-17 |
Fisons Limited |
Composition for treating airway disease
|
US4145438A
(en)
*
|
1975-09-10 |
1979-03-20 |
Fisons Limited |
Method for treatment of eczema or psoriasis
|
US4067992A
(en)
*
|
1975-09-10 |
1978-01-10 |
Fisons Limited |
Method of treating a psychiatric condition
|
GB1509979A
(en)
*
|
1975-11-28 |
1978-05-10 |
Fisons Ltd |
Pharmaceutical compositions containing aspirin or indomethacin
|
US4097596A
(en)
*
|
1976-11-02 |
1978-06-27 |
American Home Products Corporation |
Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
|
GB1557082A
(en)
*
|
1977-01-25 |
1979-12-05 |
Fisons Ltd |
Pharmaceutical mixture containing an antiinflammatory
|
US4192860A
(en)
*
|
1977-05-06 |
1980-03-11 |
Fisons Limited |
Methods for treating disease conditions
|
NZ187192A
(en)
*
|
1977-05-06 |
1982-02-23 |
Fisons Ltd |
Prophylactic or curative treatment of allergic conditions in domestic animals using compounds with sodium cromoglycate-like activity
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
FI802783A
(fi)
*
|
1979-09-05 |
1981-03-06 |
Glaxo Group Ltd |
Fenolderivat
|
GB2077100B
(en)
*
|
1980-04-30 |
1985-04-24 |
Fisons Ltd |
Pharmaceutical compositions containing cromoglycates
|
EP0061800B1
(en)
*
|
1981-03-24 |
1985-08-28 |
FISONS plc |
Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
|
JPS5828509U
(ja)
*
|
1981-08-20 |
1983-02-24 |
関東電気工事株式会社 |
分岐箇所用低圧ロ−ラ
|
US4584315A
(en)
*
|
1981-11-16 |
1986-04-22 |
The Upjohn Company |
Method of treating ischemic states
|
US4447449A
(en)
*
|
1981-11-16 |
1984-05-08 |
The Upjohn Company |
Methods of treating ischemic states
|
US5135940A
(en)
*
|
1982-09-23 |
1992-08-04 |
Merck Frosst Canada, Inc. |
Leukotriene antagonists
|
US4782176A
(en)
*
|
1983-01-24 |
1988-11-01 |
Hoffmann-La Roche Inc. |
Phenoxycarboxylic acids
|
US4581225A
(en)
*
|
1984-04-25 |
1986-04-08 |
Eli Lilly And Company |
Sustained release intranasal formulation and method of use thereof
|
DE3786030T2
(de)
|
1986-03-27 |
1993-12-02 |
Merck Frosst Canada Inc |
Tetrahydrocarbazole Ester.
|
US4758678A
(en)
*
|
1986-07-18 |
1988-07-19 |
Pennwalt Corporation |
Preparation of 7-(2,3-epoxypropoxy)flavone
|
US5788983A
(en)
*
|
1989-04-03 |
1998-08-04 |
Rutgers, The State University Of New Jersey |
Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
|
EP0480716A1
(en)
|
1990-10-12 |
1992-04-15 |
Merck Frosst Canada Inc. |
Saturated hydroxyalkylquinoline acids as leukotriene antagonists
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
GB9317752D0
(en)
*
|
1993-08-26 |
1993-10-13 |
Fisons Plc |
New pharmaceutical use
|
US5508451A
(en)
*
|
1994-07-07 |
1996-04-16 |
Hoechst Celanese Corporation |
Process for the preparation of dialkali metal cromoglycates
|
ATE236617T1
(de)
|
1994-12-22 |
2003-04-15 |
Astrazeneca Ab |
Aerosol-arzneiformulierungen
|
ATE238043T1
(de)
*
|
1994-12-22 |
2003-05-15 |
Astrazeneca Ab |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
CA2174583A1
(en)
*
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
US6150400A
(en)
*
|
1997-06-30 |
2000-11-21 |
Presutti Laboratories |
Method for treating vulvar vestibulitis
|
US6596284B1
(en)
|
2002-04-30 |
2003-07-22 |
Thomas E. Fleming |
Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
|
US20050026880A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
WO2009131695A1
(en)
|
2008-04-25 |
2009-10-29 |
Nektar Therapeutics |
Oligomer-bis-chromonyl compound conjugates
|
US8617517B2
(en)
|
2009-01-29 |
2013-12-31 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
TR201000733A2
(tr)
|
2010-02-02 |
2011-08-22 |
Bi̇lgi̇ç Mahmut |
Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
|
US20140249180A1
(en)
*
|
2011-10-03 |
2014-09-04 |
National Center For Geriatrics And Gerontology |
Tau aggregation inhibitor
|
JP6499077B2
(ja)
|
2012-10-25 |
2019-04-10 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病と関連疾患の治療のための併用療法
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
US9907799B2
(en)
|
2013-04-02 |
2018-03-06 |
The Doshisha |
Tau aggregation inhibitor
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
CN110305095A
(zh)
|
2013-10-22 |
2019-10-08 |
综合医院公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
ES2792682T3
(es)
|
2014-02-10 |
2020-11-11 |
Respivant Sciences Gmbh |
Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
|
PT3104853T
(pt)
|
2014-02-10 |
2020-01-14 |
Respivant Sciences Gmbh |
Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
CA3035528A1
(en)
|
2016-08-31 |
2018-03-08 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
JP2019524865A
(ja)
|
2016-08-31 |
2019-09-05 |
ザ ジェネラル ホスピタル コーポレイション |
神経変性疾患と関連する神経炎症におけるマクロファージ/ミクログリア
|
CN109803724A
(zh)
|
2016-10-07 |
2019-05-24 |
瑞思皮万特科学有限责任公司 |
用于治疗肺纤维化的色甘酸组合物
|
AU2017423862A1
(en)
|
2017-07-20 |
2020-02-06 |
Aztherapies, Inc. |
Powdered formulations of cromolyn sodium and ibuprofen
|
JP2021529771A
(ja)
|
2018-07-02 |
2021-11-04 |
ザ ジェネラル ホスピタル コーポレイション |
クロモリンナトリウムおよびα−ラクトースの粉末製剤
|
US20220387408A1
(en)
|
2019-11-12 |
2022-12-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction
|